Medline Inc. (‘Medline’), together with its subsidiaries, provides medical-surgical (‘med-surg’) products and supply chain solutions.
Medline delivers mission-critical products used daily across the full range of care settings, from hospitals and su…
Analysis
Middle-of-the-road
Medline Inc. sits in the middle of our grid: average quality, average price, no obvious signal in either direction.
On valuation, the picture is fair. The owner-earnings multiple stands at 20.8×; owner earnings: the cash an owner could take out each year. The implied growth embedded in that price is around 7% a year, against analyst forecasts of 5%. The price, in other words, assumes less than the experts do.
Growth is moderate; the safety picture is stretched. The company scores 10/20 on our value-creation score: creating some value.
No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.
360° rank · history
1007550250
Mar 202694
44
2026
All-time high
94
Mar 2026
All-time low
44
Jun 2026
Average rank
69
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Current202520242023
Price/Sales
89
—
—
—
Price/Earnings
45
—
—
—
Price/Book
62
—
—
—
Dividend Yield
1
—
—
—
Value (overall)
65
—
—
—
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.